Francisco Colon, MD
Plastic and Reconstructive Surgery · Florham Park, NJNPI 1770574410
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $13,194 of the $15,827 with a category attached, or 83.4%. AbbVie accounts for 95.4% of it on its own, with 8 other manufacturers making up the rest. Among plastic and reconstructive surgery clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 156 payments — averaging $101.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$15K
- Revance Therapeutics, Inc.$528
- Mentor Worldwide LLC$58
- Musculoskeletal Transplant Foundation Inc.$56
- Solta Medical, A Division Of Bausch Health US, LLC$27
- Motiva USA, LLC$18
- plus $45 from 3 others
What the payments were for
- Speaking & faculty fees$13,19483%
- Food & beverage$2,63317%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 128 | $15,094 |
| Revance Therapeutics, Inc. | 21 | $528 |
| Mentor Worldwide LLC | 1 | $58 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $56 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $27 |
| Motiva USA, LLC | 1 | $18 |
| Tepha Inc | 1 | $17 |
| TELA Bio, Inc. | 1 | $15 |
| Acelrx Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,827 in reported general payments places this provider in the 90th percentile of 93 plastic and reconstructive surgery providers in New Jersey.
See all plastic and reconstructive surgery providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tranexamic Acid | 14 | $272 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 14 | $185 |
| Cephalexin | 13 | $84 |
| Oxycodone Hcl | 15 | $62 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Florham Park
- Eric ChangFlorham Park$41K
- Colin FaileyFlorham Park$40K
- Sara ColeCherry Hill$63K
- Edward LeeRahway$50K
- Steve FallekEnglewood$34K
- Barry DibernardoMontclair$31K
- Michael NagyManasquan$27K
- John TaylorRed Bank$18K
- Peter AndrawesRed Bank$11K
- Brian Bassiri-TehraniEnglewood$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.